Abingdon Health is a world leading developer and manufacturer of high-quality rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon Health works with global partners and takes projects from initial concept through to routine and large-scale manufacturing. We can also support clients as a new or second lateral flow manufacturer to scale-up newly developed lateral flow assays or increase output for tests already on the market. We are conducting no-obligation project consultation during Medica 2021.
The Company offers:
- product development
- regulatory support
- technology transfer
- manufacturing services
Abingdon Health has also developed and marketed its own labelled tests. The latest being AbC-19, a rapid test that detects IgG neutralising antibodies to the SARS-CoV-2 spike protein. We are looking for distributors to join our network. Speak with us at Medica 2021.
Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. Something we are proud to be a part of!